Compound ID | 3405

Update compound information

LMN-201

Synonym(s): LMN 201  |  LMN201  |  LMN-Cdiff01

Class: Bacteriophage and phage-derived enzyme

Spectrum of activity: Gram-positive
Details of activity: Active against Clostridioides difficile; indicated for recurrent C. difficile infection; antibody-like proteins neutralize bacterial toxin whilst enzyme-protein targets Clostridium difficile cell wall
Description: Contains antibody-like proteins and cell-wall degrading enzyme
Institute where first reported: Lumen Bioscience
Year first mentioned: 2022
Highest developmental phase: Phase 3
Development status: Active
External links:
Citations:
  • https://doi.org/10.1101/2021.12.21.473715
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC9953237/#B107-biomedicines-11-00426
  • https://pmc.ncbi.nlm.nih.gov/articles/PMC9953237/

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.